Skip to main content
Retour
Watch Compare

USANA HEALTH SCIENCES INC

Qualité des données : 100%
USNA
NYSE Manufacturing Chemicals
18,38 €
▲ 0,31 € (1,72%)
Cap. Boursière: 339,24 M
Prix
18,38 €
Cap. Boursière
339,24 M
Fourchette du Jour
17,60 € — 18,38 €
Fourchette 52 Semaines
16,60 € — 38,32 €
Volume
64 483
Ouverture 17,91 €
Moyenne 50J / 200J
19,46 €
5,57% below
Moyenne 50J / 200J
24,02 €
23,49% below

Quick Summary

Points Clés

Earnings declined -83,13% over the past year
ROE of 2,03% is below average
Generating 8,53 M in free cash flow
P/E of 31,53 — premium valuation
Capital efficient — spends only 1,49% of revenue on capex
ROIC of 3,07% — low return on invested capital

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)0,46%
Earnings (1Y)-83,13%
FCF Growth (3Y)-69,80%

Qualité

Return on Equity
2,03%
Au-dessus de la moyenne du secteur (-53,41%)
ROIC3,07%
Net Margin1,16%
Op. Margin4,05%

Sécurité

Debt / Equity
N/A
Current Ratio2,23
Interest Coverage44,46

Valorisation

PE (TTM)
31,53
Au-dessus de la moyenne du secteur (-1,48)
P/B Ratio0,64
EV/EBITDA2,77
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E 31,5 -1,5
P/B 0,6 1,6
ROE % 2,0 -53,4
Net Margin % 1,2 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

ETFs Holding This Stock

PZISX PZISX
1,05% weight
DEEP logo DEEP Acquirers Small and Micro Deep Value ETF
0,93% weight
DSMC logo DSMC Distillate Small/Mid Cash Flow ETF
0,46% weight
SQLV logo SQLV Royce Quant Small-Cap Quality Value ETF
0,33% weight
QWVOX QWVOX
0,24% weight
BOGIX BOGIX
0,10% weight
BSVO logo BSVO EA Bridgeway Omni Small-Cap Value ETF
0,09% weight
TSVAX TSVAX
0,08% weight
TASVX TASVX
0,08% weight
TSVRX TSVRX
0,08% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 0,46% Revenue Growth (3Y) -3,74%
Earnings Growth (1Y) -83,13% Earnings Growth (3Y) -60,61%
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 925,26 M Net Income (TTM) 10,76 M
ROE 2,03% ROA 1,47%
Gross Margin 78,29% Operating Margin 4,05%
Net Margin 1,16% Free Cash Flow (TTM) 8,53 M
ROIC 3,07% FCF Growth (3Y) -69,80%
Safety
Debt / Equity N/A Current Ratio 2,23
Interest Coverage 44,46 Asset Turnover 1,27
Working Capital 145,40 M Tangible Book Value 245,63 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 31,53 Forward P/E N/A
P/B Ratio 0,64 P/S Ratio 0,37
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 2,77 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 2,51%
Market Cap 339,24 M Enterprise Value 193,89 M
Per Share
EPS (Diluted TTM) 0,58 Revenue / Share 50,13
FCF / Share 0,46 OCF / Share 1,21
EPS CAGR (1Y) -82,42% EPS CAGR (5Y) N/A
EPS CAGR (10Y) -19,29%
Efficiency
CapEx / Revenue 1,49% FCF Conversion 79,24%
SBC-Adj. FCF -5,09 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2023 FY2022 FY2020 FY2019
Revenue 925,26 M 921,01 M 998,60 M 1,13 B 1,06 B
Net Income 10,76 M 63,79 M 69,35 M 124,66 M 100,53 M
EPS (Diluted) 0,58 3,30 3,59 5,86 4,41
Gross Profit 724,41 M 744,32 M 804,71 M 925,53 M 873,40 M
Operating Income 37,43 M 93,07 M 107,61 M 176,49 M 146,19 M
EBITDA — — — — —
R&D Expenses 10,69 M 11,45 M 11,56 M 10,63 M 10,26 M
SG&A Expenses 337,37 M 256,99 M 262,30 M 261,19 M 267,73 M
D&A 32,56 M 12,70 M 13,39 M 13,75 M 14,74 M
Interest Expense 842 000,0 262 000,0 192 000,0 507 000,0 66 000,0
Income Tax 30,05 M 38,67 M 39,27 M 53,28 M 49,97 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2023 FY2022 FY2020 FY2019
Total Assets 742,92 M 632,76 M 596,55 M 640,89 M 516,93 M
Total Liabilities 156,64 M 135,56 M — — —
Shareholders' Equity 533,10 M 497,20 M 434,47 M 441,65 M 351,71 M
Total Debt — — — — —
Cash & Equivalents 158,38 M 330,42 M 288,42 M 311,92 M 234,83 M
Current Assets 288,41 M 417,75 M 384,38 M 425,29 M 329,28 M
Current Liabilities 128,57 M 118,85 M 143,83 M 168,07 M 136,10 M